26 February 2019 - Families in England are preparing to leave the country in a desperate bid to obtain a cystic fibrosis drug not available at home.

Soon after Emma Corr, a teacher in northeast England, gave birth to her second daughter in 2014, she was devastated to learn that her baby had cystic fibrosis, a life-shortening genetic disease that causes severe lung damage. Then she heard about a promising new drug nearing the market that might transform her child’s life.

“It was a glimmer of hope at a very dark time,” says Corr, whose daughter, Harriet, is one of 10,000 people in the U.K. afflicted with the illness.

Read Bloomberg article